Bank of America’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
416,203
+45
| +0% | +$14 | ﹤0.01% | 5439 |
|
|
2025
Q1 | $118K | Buy |
416,158
+15
| +0% | +$4 | ﹤0.01% | 5442 |
|
|
2024
Q4 | $244K | Sell |
416,143
-12,635
| -3% | -$7.4K | ﹤0.01% | 5156 |
|
|
2024
Q3 | $191K | Buy |
428,778
+200,123
| +88% | +$89.3K | ﹤0.01% | 5159 |
|
|
2024
Q2 | $606K | Buy |
228,655
+253
| +0.1% | +$670 | ﹤0.01% | 4476 |
|
|
2024
Q1 | $626K | Buy |
228,402
+179,706
| +369% | +$492K | ﹤0.01% | 4418 |
|
|
2023
Q4 | $118K | Sell |
48,696
-409,381
| -89% | -$995K | ﹤0.01% | 5393 |
|
|
2023
Q3 | $925K | Sell |
458,077
-11,634
| -2% | -$23.5K | ﹤0.01% | 4072 |
|
|
2023
Q2 | $1.39M | Sell |
469,711
-3,928
| -0.8% | -$11.6K | ﹤0.01% | 3795 |
|
|
2023
Q1 | $1.18M | Buy |
473,639
+4,474
| +1% | +$11.2K | ﹤0.01% | 4091 |
|
|
2022
Q4 | $1.49M | Sell |
469,165
-20,089
| -4% | -$63.7K | ﹤0.01% | 3906 |
|
|
2022
Q3 | $1.45M | Buy |
489,254
+60,764
| +14% | +$180K | ﹤0.01% | 3923 |
|
|
2022
Q2 | $1.31M | Buy |
428,490
+69,748
| +19% | +$213K | ﹤0.01% | 4035 |
|
|
2022
Q1 | $4.84M | Buy |
358,742
+120,876
| +51% | +$1.63M | ﹤0.01% | 3177 |
|
|
2021
Q4 | $3.1M | Buy |
237,866
+24,635
| +12% | +$321K | ﹤0.01% | 3531 |
|
|
2021
Q3 | $2M | Buy |
213,231
+196,482
| +1,173% | +$1.84M | ﹤0.01% | 3801 |
|
|
2021
Q2 | $172K | Buy |
16,749
+6,036
| +56% | +$62K | ﹤0.01% | 5423 |
|
|
2021
Q1 | $197K | Sell |
10,713
-96,716
| -90% | -$1.78M | ﹤0.01% | 5395 |
|
|
2020
Q4 | $3.68M | Buy |
107,429
+92,612
| +625% | +$3.17M | ﹤0.01% | 2942 |
|
|
2020
Q3 | $274K | Buy |
+14,817
| New | +$274K | ﹤0.01% | 4512 |
|